Screening for Pre Eclampsia

Pre-eclampsia is a serious medical condition that can occur after 20 weeks of pregnancy. It typically causes high blood pressure and can affect several of your body organs, including the liver, kidney and brain. If left untreated, it can lead to serious problems for you or your baby.

Screening-for-Pre-Eclampsia
FAQs

  • Preeclampsia is one of the complications of pregnancy. Preeclampsia can lead to serious, even fatal complications for both the mother and baby. Quite often, the problem is detected after the onset of Preeclampsia as conventional methods of its detection are not reliable. Screening for Preeclampsia using biomarkers from a blood sample, is much more reliable and is also able to predict its onset so that the clinician can be well prepared to manage the complication due to Preeclampsia.

  • Both ultrasound and blood tests can be performed at Gestational ages of 11 to 14 weeks in the first trimester or 18 to 21 weeks in the second trimester or 28 to 32 weeks in the third trimester to assess the risk of Preeclampsia.

  • Conventional approaches to assess the risk of Preeclampsia was based on sudden and sharp increase in blood pressure or for the presence of protein in urine. However these clinical conditions need not always be the first to increase and therefore can be misleading and quite likely that the risk is not assessed accurately. Current approaches recommend the use of protein biomarker based blood tests along with clinical assessment to predict and to assess the risk.

  • You don’t have to do any special preparation before the procedure. Our experts will tell you if you need to have a full bladder for the test depending on the circumstances.

  • MediScan is an acknowledged centre of excellence in Asia for fetal medicine. They have helped improve standard of care for pregnancies and have pioneered new assessment metrics and tools to determine the normalcy, safety and viability of the pregnancy. This therefore results in accuracy and reliability of its screening and diagnostic services.

Previous

Screening for Chromosmal Abnormalities